• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Phio Pharmaceuticals Corp (NQ: PHIO )

    3.600 -0.170 (-4.51%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 162,217
    Open 3.800
    Bid (Size) 3.600 (7)
    Ask (Size) 3.680 (4)
    Prev. Close 3.770
    Today's Range 3.350 - 3.960
    52wk Range 0.5000 - 6.195
    Shares Outstanding 4,591,700
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds
    Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company... 
    Via Newsfile
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762
    Five sites across the U.S. are now participating in the Phase 1b study Marlborough, Massachusetts--(Newsfile Corp. - July 8,... 
    Via Newsfile

    Performance

    YTD
    +367.71%
    +367.71%
    1 Month
    +407.04%
    +407.04%
    3 Month
    +436.51%
    +436.51%
    6 Month
    +437.88%
    +437.88%
    1 Year
    +29.73%
    +29.73%

    More News

    Read More
    Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds
    Via Newsfile
    Phio Pharmaceuticals Announces Reverse Stock Split
    Via Newsfile
    PHIO Stock Earnings: Phio Pharma Reported Results for Q1 2024
    Via InvestorPlace
    Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging
    Via Newsfile
    Topics Intellectual Property
    Exposures Intellectual Property
    Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762
    Via Newsfile
    Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
    Via Newsfile
    Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
    From Phio Pharmaceuticals Corp.
    Via GlobeNewswire
    Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Why Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?
    Via Benzinga
    PHIO Stock Earnings: Phio Pharma Beats EPS for Q4 2023
    Via InvestorPlace
    Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
    From Phio Pharmaceuticals Corp.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Dow Surges 100 Points; Ciena Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.